Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.

[1]  M. Tanimoto,et al.  Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission , 1998, Bone Marrow Transplantation.

[2]  J P Kahan,et al.  The reproducibility of a method to identify the overuse and underuse of medical procedures. , 1998, The New England journal of medicine.

[3]  Keith Wheatley,et al.  Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial , 1998, The Lancet.

[4]  P. Hurteloup,et al.  Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM). , 1997, Blood.

[5]  M A Hlatky,et al.  Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. , 1996, The New England journal of medicine.

[6]  E. Thiel,et al.  Long-Term Follow-up of Adults with Acute Lymphoblastic Leukemia in First Remission Treated with Chemotherapy or Bone Marrow Transplantation , 1995, Annals of Internal Medicine.

[7]  R. Kravitz,et al.  Validity of criteria used for detecting underuse of coronary revascularization. , 1995, JAMA.

[8]  D. Hunter,et al.  Qualitative Research: Consensus methods for medical and health services research , 1995 .

[9]  P. Rothwell,et al.  Can overall results of clinical trials be applied to all patients? , 1995, The Lancet.

[10]  B. Löwenberg.  Post-remission treatment of acute myelogenous leukemia. , 1995, The New England journal of medicine.

[11]  F. Mandelli,et al.  Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. , 1995, The New England journal of medicine.

[12]  C. Sebban,et al.  Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. , 1994, Journal of Clinical Oncology.

[13]  C. Hamm,et al.  A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) , 1994, The New England journal of medicine.

[14]  M. Kutner,et al.  A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery , 1994 .

[15]  F. Appelbaum,et al.  Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. , 1994, Blood.

[16]  W. Woods,et al.  Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: risk factors and clinical outcome , 1994, British journal of haematology.

[17]  J. Kersey.  Bone-marrow transplantation for acute lymphoblastic leukemia. , 1993, The New England journal of medicine.

[18]  S. Woolf.  Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. , 1992, Archives of internal medicine.

[19]  S. Woolf,et al.  Practice guidelines: a new reality in medicine. I. Recent developments. , 1990, Archives of internal medicine.

[20]  K. Kahn,et al.  Physician ratings of appropriate indications for six medical and surgical procedures. , 1986, American journal of public health.

[21]  R H Brook,et al.  A Method for the Detailed Assessment of the Appropriateness of Medical Technologies , 1986, International Journal of Technology Assessment in Health Care.

[22]  M. Desai,et al.  Bone marrow transplantation for acute lymphoblastic leukaemia , 1982, British journal of haematology.

[23]  P. Shekelle,et al.  Assessing the Predictive Validity of the RAND/UCLA Appropriateness Method Criteria for Performing Carotid Endarterectomy , 1998, International Journal of Technology Assessment in Health Care.

[24]  C. Buckner,et al.  Marrow transplantation for acute myeloid leukemia. , 1998, Cancer investigation.

[25]  M. Wolin,et al.  Therapy of acute myelogenous leukemia: understanding the question, understanding the answer. , 1997, Leukemia research.

[26]  J. Klein,et al.  HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. , 1996, Leukemia.

[27]  A. Grañena,et al.  Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). , 1996, Bone marrow transplantation.

[28]  J. Armitage,et al.  Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America. , 1994, Clinical transplants.

[29]  H. Lazarus,et al.  Bone marrow transplantation for acute lymphoblastic leukemia(all) , 1994, Medical oncology.

[30]  Barrett Aj.  Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia , 1992 .